Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Drew Weissman and Barton Haynes.
Drew Weissman
Connection Strength
1.386
Barton Haynes
  1. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses. Nature. 2021 06; 594(7864):553-559.
    View in: PubMed
    Score: 0.236
  2. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates. NPJ Vaccines. 2021 Apr 09; 6(1):50.
    View in: PubMed
    Score: 0.235
  3. D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization. Cell Host Microbe. 2021 01 13; 29(1):23-31.e4.
    View in: PubMed
    Score: 0.229
  4. Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques. Mol Ther Nucleic Acids. 2019 Apr 15; 15:36-47.
    View in: PubMed
    Score: 0.204
  5. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. J Exp Med. 2018 06 04; 215(6):1571-1588.
    View in: PubMed
    Score: 0.192
  6. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature. 2017 03 09; 543(7644):248-251.
    View in: PubMed
    Score: 0.176
  7. Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice. Science. 2021 08 27; 373(6558):991-998.
    View in: PubMed
    Score: 0.060
  8. A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. Immunity. 2020 10 13; 53(4):724-732.e7.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.